You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 60631-0412


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 60631-0412

Drug NameNDCPrice/Unit ($)UnitDate
EDARBYCLOR 40-12.5 MG TABLET 60631-0412-30 8.50564 EACH 2025-01-01
EDARBYCLOR 40-12.5 MG TABLET 60631-0412-30 7.80327 EACH 2024-12-18
EDARBYCLOR 40-12.5 MG TABLET 60631-0412-30 7.80493 EACH 2024-11-20
EDARBYCLOR 40-12.5 MG TABLET 60631-0412-30 7.79676 EACH 2024-10-23
EDARBYCLOR 40-12.5 MG TABLET 60631-0412-30 7.81034 EACH 2024-09-18
EDARBYCLOR 40-12.5 MG TABLET 60631-0412-30 7.80843 EACH 2024-08-21
EDARBYCLOR 40-12.5 MG TABLET 60631-0412-30 7.81330 EACH 2024-07-17
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 60631-0412

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for EDARBYCLOR (NDC: 60631-0412)

Overview of EDARBYCLOR

EDARBYCLOR, a combination medication of azilsartan medoxomil and chlorthalidone, is used to treat high blood pressure. It is part of the broader hypertension treatment market, which is anticipated to grow significantly due to the increasing prevalence of hypertension globally[1].

Current Pricing

As of the latest data available in 2024, the prices for EDARBYCLOR tablets are as follows:

  • EDARBYCLOR 40-12.5 MG TABLET (NDC: 60631-0412-30): The price per unit was approximately $7.80 as of December 2024[1].

Market Trends and Price Increases

The pharmaceutical industry, including the market for hypertension treatments, is characterized by periodic price increases, particularly in January and July each year. Here are some key trends:

  • Frequency of Price Increases: Most prescription drug price increases occur in January and July, with January seeing the highest number of increases. In 2022, over 3,000 drugs experienced a price increase in January, and this trend is expected to continue[2].
  • Magnitude of Price Increases: The average price increase in January 2022 was nearly $150 per drug (10% increase), while in July 2022, it was $250 (7.8% increase). These increases are often higher for more expensive drugs[2].

Impact of General Inflation

The recent high rate of general inflation has also influenced drug price increases. For instance, between July 2021 and July 2022, the Consumer Price Index (CPI-U) increased by 8.5%, and while the average July 2022 price increase was slightly below this rate, many drugs still exceeded general inflation levels[2].

Future Outlook and Projections

Given the broader trends in the pharmaceutical industry, here are some projections and considerations for EDARBYCLOR:

  • Growth in Hypertension Treatment Market: The hypertension treatment market is expected to grow significantly due to the increasing prevalence of hypertension. This growth will likely support the demand for EDARBYCLOR and other similar medications[1].
  • Technological Advancements: The pharmaceutical industry is investing heavily in data, AI, and digital tools to improve drug development and supply chain efficiency. While these advancements may not directly impact the price of existing drugs like EDARBYCLOR, they could influence the overall market dynamics and pricing strategies[3].
  • Regulatory and Economic Factors: Proposed legislation and geopolitical changes can affect domestic manufacturing and supply chain strategies. These factors might lead to price adjustments as companies adapt to new regulatory environments and economic conditions[3].

Price Projections

Based on historical trends and industry projections:

  • Short-Term Projections: For the next year, it is likely that EDARBYCLOR will experience price increases similar to those seen in previous years, potentially around 10% in January and 7-8% in July, aligning with industry averages[2].
  • Long-Term Projections: Over the next few years, the price of EDARBYCLOR could continue to rise, albeit at a rate that may be influenced by general inflation and specific market conditions. Given the growth in the hypertension treatment market, prices may remain stable or increase slightly above inflation rates.

Key Takeaways

  • Market Growth: The hypertension treatment market is expected to grow, supporting demand for EDARBYCLOR.
  • Price Increases: Periodic price increases, especially in January and July, are likely to continue.
  • Technological and Regulatory Factors: Advancements in technology and changes in regulatory environments could influence pricing strategies.
  • Inflation Impact: General inflation rates will continue to play a role in drug price adjustments.

FAQs

  1. What is the current price of EDARBYCLOR 40-12.5 MG TABLET?

    • As of December 2024, the price per unit is approximately $7.80[1].
  2. When are the most significant price increases for prescription drugs?

    • The most significant price increases typically occur in January and July each year[2].
  3. How does general inflation affect drug prices?

    • Drug price increases often align with or slightly exceed general inflation rates, especially in periods of high inflation[2].
  4. What technological advancements are impacting the pharmaceutical industry?

    • The industry is investing in data, AI, and digital tools to improve drug development and supply chain efficiency[3].
  5. How might regulatory changes affect the price of EDARBYCLOR?

    • Regulatory changes and geopolitical factors can influence domestic manufacturing and supply chain strategies, potentially leading to price adjustments[3].

Sources

  1. DrugPatentWatch - Pharmaceutical drug prices and trends for EDARBYCLOR[1].
  2. ASPE - Price Increases for Prescription Drugs, 2016-2022[2].
  3. ZS - Exploring 2025 pharma industry trends, outlook and strategies[3].
  4. BusinessWire - Drug Discovery Technologies Global Research Report 2024[4].
  5. Medicaid - For State Technical Contacts - Medicaid[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.